Melanoma Stage IIIB
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients (NCT03567889) | Philogen S.p.A. | 2018-09-20 |
Track Melanoma Stage IIIB automatically
Every clearance here is in the API, with alerts when new ones post.